GSK Plc (GSK)
60.23
+1.06
(+1.79%)
USD |
NYSE |
Feb 06, 16:00
60.00
-0.23
(-0.38%)
After-Hours: 20:00
GSK Cash and Short Term Investments (Quarterly) : 4.581B for Dec. 31, 2025
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AstraZeneca PLC | 8.182B |
| Mereo BioPharma Group Plc | 48.70M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 33.99M |
| AnaptysBio, Inc. | 248.96M |